StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Mereo BioPharma's EPS for the twelve months ending Sep 30, 2026 was -$0.04. For fiscal 2025 it was -$0.05.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.05–
FY2024Dec 31, 2024-$0.06–
FY2023Dec 31, 2023-$0.04–
FY2022Dec 31, 2022-$0.07–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.01–
Q2 FY2026Jun 30, 2026-$0.01–
Q1 FY2026Mar 31, 2026-$0.01–
Q4 FY2025Dec 31, 2025-$0.01–
Q3 FY2025Sep 30, 2025-$0.01–
Q2 FY2025Jun 30, 2025-$0.02–
Q1 FY2025Mar 31, 2025-$0.02–
Q4 FY2024Dec 31, 2024-$0.01–
Q3 FY2024Sep 30, 2024-$0.02–
Q2 FY2024Jun 30, 2024-$0.02–
Q1 FY2024Mar 31, 2024-$0.01–
Q4 FY2023Dec 31, 2023-$0.01–
Q3 FY2023Sep 30, 2023-$0.01–
Q2 FY2023Jun 30, 2023$0.00–
Q1 FY2023Mar 31, 2023-$0.02–

More Mereo BioPharma figures

See a number that looks wrong?